There is evidence that proves the feasibility of such an effective vaccine design to prevent leishmaniasis. It is based on first identifying the compounds that the parasite uses to cause the pathology, isolating them, and finally introducing those compounds into the body in a safe manner, giving the immune system a chance to be alert against a possible infection.
Leishmaniasis is a disease caused by a protozoan intracellular parasite of the genus Leishmania that exhibits diverse symptoms and pathologies. These parasites are transmitted by a dipterous insect know as a sand fly (Phlebotomus), that acts as a vector for the disease and its genus differs depending on the geographical area. Human leishmaniasis is widely distributed around the globe and according to data from the WHO there are currently around 12 million people infected and 350 million people living under the threat of the disease in 88 different countries, mainly in tropical and subtropical regions.
In Spain, canine leishmaniasis constitutes a huge problem with 50% of infected dogs developing the pathology. In most cases it ends with the death of the animal, mainly because treatments are not efficient and have highly toxic side effects. Therefore, the house dog is considered the main hide-out for Leishmania infantum in the mediterranean area, playing a key role in the transmission of the parasite into humans through the sand fly. It should also be pointed out that the cases of leishmaniasis in patients suffering from advanced stages of AIDS with weakened immune systems is increasing. And although these cases are not as frequent, there are recently described cases of Leishmaniasis in cats and some horse species in many Mediterranean as well as South American countries.
Among the determining factors for the control of the disease, the virulence of the species of leishmania involved and the genetic predisposition of the host are crucial. Based on the symptoms of the disease, leishmania has been classified in to 4 different types: cutaneous, diffuse cutaneous, mucocutaneous and visceral. Many of the compounds of leishmania are invisible to the immune system, which allows the parasite to avoid our antimicrobial defences and establish an infection. Later, when the parasite starts to disseminate through the organism, other compounds (pathoantigens) are visible to the immune system and are vital for understanding the pathology.
In this context, the work carried out at the Molecular biology research centre Severo Ochoa (CSIC-UAM) by researchers from the parasitology group, formed among others by Doctors Javier Carrión and Carlos Alonso, has been focused on Histones, (proteins responsible for the packaging of DNA). As their latest published work (february edition of Vaccine) states: histones are one of the most important compounds that the parasite uses to define its degree of virulence. Through the isolation of the compounds and using different methodologies available in the molecular parasitology scientific field these researchers have developed immunization strategies that offer an outlook of a bright future in which a vaccine against leishmaniasis is a reality.
GLUT5 fluorescent probe fingerprints cancer cells
20.04.2018 | Michigan Technological University
Scientists re-create brain neurons to study obesity and personalize treatment
20.04.2018 | Cedars-Sinai Medical Center
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
24.04.2018 | Information Technology
24.04.2018 | Earth Sciences
24.04.2018 | Life Sciences